Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China flag China · Delayed Price · Currency is CNY
13.23
-0.19 (-1.42%)
At close: Feb 13, 2026

SHE:300246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
648.3466.39498.72437.03336.55430.86
Short-Term Investments
-263.97322.21342.83--
Trading Asset Securities
18.48----52.2
Cash & Short-Term Investments
666.78730.35820.93779.86336.55483.06
Cash Growth
49.31%-11.03%5.27%131.72%-30.33%159.83%
Accounts Receivable
265.45262.44261.25297.24232.03191.8
Other Receivables
22.7554.7227.5925.2226.2613.89
Receivables
288.2317.16288.84322.46258.29205.69
Inventory
281.68232.07220.37200.57193.5148.18
Other Current Assets
51.1154.141.263341.4129.53
Total Current Assets
1,2881,3341,3711,336829.76866.46
Property, Plant & Equipment
893.32911.18888.73737.85584.72442.18
Long-Term Investments
12.9313.848.538.699.835.5
Goodwill
25.1525.1540.67127.13127.13136.59
Other Intangible Assets
107.16101.6398.0894.5190.5189.38
Long-Term Accounts Receivable
12.344.125.59---
Long-Term Deferred Tax Assets
34.4529.1918.132510.486.03
Long-Term Deferred Charges
37.9339.8140.8525.9131.8530.13
Other Long-Term Assets
116.940.2162.4383.9735.2430.9
Total Assets
2,5282,4992,5342,4391,7201,607
Accounts Payable
219.68206.49246.8221.26178.44133.13
Accrued Expenses
13.1943.538.8749.5737.3557.31
Short-Term Debt
159.43188.14220.41132.64130.66105.5
Current Portion of Long-Term Debt
247.2740.750.3714.558.06-
Current Portion of Leases
-6.656.455.954.47-
Current Income Taxes Payable
4.371.983.083.983.377.17
Current Unearned Revenue
50.0643.7569.3976.0148.0847.65
Other Current Liabilities
102.04144.61135.3499.4386.7743.89
Total Current Liabilities
796.05675.82770.7603.39497.2394.65
Long-Term Debt
277.18388.05284.16252.97205.21162.21
Long-Term Leases
19.122.1923.6121.468.12-
Long-Term Unearned Revenue
135.94106.9450.345.389.3210.4
Long-Term Deferred Tax Liabilities
12.7914.7214.8713.487.257.07
Other Long-Term Liabilities
--1.81-0.03-
Total Liabilities
1,2411,2081,145936.68727.13574.33
Common Stock
264.58264.58264.58175.79146.09146.09
Additional Paid-In Capital
408.06408.04408.03504.38-15.83
Retained Earnings
504.7513.04584.48684.82698.15701.16
Treasury Stock
-20.01-20.01----
Comprehensive Income & Other
54.5853.0453.8151.0949.6454.85
Total Common Equity
1,2121,2191,3111,416893.89917.93
Minority Interest
74.9972.4378.0586.1798.49114.9
Shareholders' Equity
1,2871,2911,3891,502992.381,033
Total Liabilities & Equity
2,5282,4992,5342,4391,7201,607
Total Debt
702.98645.72584.99427.57356.52267.71
Net Cash (Debt)
-36.2184.63235.94352.29-19.97215.35
Net Cash Growth
--64.13%-33.03%--12617.43%
Net Cash Per Share
-0.140.320.891.35-0.090.98
Filing Date Shares Outstanding
261.61261.6264.58263.68262.22219.13
Total Common Shares Outstanding
261.61261.6264.58263.68219.14219.13
Working Capital
491.71657.87600.7732.5332.56471.81
Book Value Per Share
4.634.664.955.374.084.19
Tangible Book Value
1,0801,0921,1721,194676.25691.96
Tangible Book Value Per Share
4.134.174.434.533.093.16
Buildings
-582.36308.84244.21216.58224.73
Machinery
-448.39418.44398.3361.28283.82
Construction In Progress
-127.92365.74263.45155.771.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.